G&E Herbal Biotechnology Co., Ltd. (4911.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
G&E Herbal Biotechnology Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 249.03 m TWD | 309.13 m TWD |
| Gross profit | 205.34 m TWD | 263.22 m TWD |
| Operating income | 119.65 m TWD | 152.30 m TWD |
| EBIT | 124.77 m TWD | 158.42 m TWD |
| Net income | 102.06 m TWD | 139.20 m TWD |
| Diluted EPS – continuing operations | 1.48 TWD | 2.02 TWD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
More stocks
- Global View Co Ltd (3040.TW)
- Crown Confec (005740.KS)
- Ihuman Inc (IH)
- Company K Partners Limited (307930.KQ)
- Envoy Medical, Inc. (COCH)
- Dongil Ind (004890.KS)
- Professional Computer Technology Ltd (6270.TWO)
- Partner Tech Corp. (3097.TWO)
- WIDEPOINT CORP (WYY)
- Nimbus Group AB (BOAT.ST)
- Datacentrex, Inc. (DTCX)
- Justek, Inc. (153890.KQ)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.